EDGAR Filing Documents for 9999999995-17-000582

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-17-000582

Accepted

2017-03-20 00:15:11

Documents

Effectiveness Date

2017-03-17

Registration Form

S-4

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	600
	Complete submission text file	9999999995-17-000582.txt		1813

Mailing Address 14 WALL ST. SUITE 3D NEW YORK NY 10005

Business Address 14 WALL ST. SUITE 3D NEW YORK NY 10005 212-269-2834

Dipexium Pharmaceuticals, Inc. (Filer) CIK: 0001497504 (see all company filings)